Combination anticancer therapy and pharmaceutical compositions therefore

Abstract

This invention relates to anticancer therapy and more precisely to the immunological control of cancer. Specifically this invention relates to pharmaceutical compositions incorporating as the active ingredient at least one immuno-stimulating agent with charged or central groups of general formula I wherein X, Y, A, B, R1 and R2 are as defined in the specification together with a radiotherapy method suitable to fight cancer or together with a known antineoplastic chemotherapeutic agent selected from the group consisting of alkylating agents, anti-metabolic agents, agents acting on tubules and tyrosine Kinase inhibitors in conjunction or admixture with an inert non toxic pharmaceutically acceptable diluent or carrier. This invention also relates to the salts of a compound of general formula I with a mineral or organic base, namely a pharmaceutically-acceptable base. Use for treating cancer conditions within a single container or disposed within distinct container

Dependencies are inferred from the claim text.